{"title":"因子 XII 缺乏症儿科患者的心肺搭桥术","authors":"Julie Fenske, Julie Tinius-Juliani, Cynthia Herrington","doi":"10.1051/ject/2024021","DOIUrl":null,"url":null,"abstract":"Safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complication in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in the factor XII deficient patient, however documentation of successful monitoring during CPB is infrequent. With use of the Hemochron Signature Elite and ACT+ cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions as to factor XII deficiency management with CPB.","PeriodicalId":506828,"journal":{"name":"The Journal of ExtraCorporeal Technology","volume":"117 20","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiopulmonary Bypass in a Pediatric Patient with Factor XII Deficiency\",\"authors\":\"Julie Fenske, Julie Tinius-Juliani, Cynthia Herrington\",\"doi\":\"10.1051/ject/2024021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complication in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in the factor XII deficient patient, however documentation of successful monitoring during CPB is infrequent. With use of the Hemochron Signature Elite and ACT+ cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions as to factor XII deficiency management with CPB.\",\"PeriodicalId\":506828,\"journal\":{\"name\":\"The Journal of ExtraCorporeal Technology\",\"volume\":\"117 20\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of ExtraCorporeal Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1051/ject/2024021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of ExtraCorporeal Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1051/ject/2024021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
安全使用心肺旁路术(CPB)有赖于管理、监测和逆转抗凝的能力。XII 因子缺乏的患者虽然罕见,但却给灌注医师带来了挑战,因为这会导致监测抗凝的复杂性。有人提出了帮助 XII 因子缺乏患者监测抗凝的策略,但在 CPB 期间成功监测的记录并不多见。使用 Hemochron Signature Elite 和 ACT+ 血盒后,一名 XII 因子缺乏的 8 个月大婴儿在可预测和可靠的抗凝监测下完成了 CPB。本病例报告探讨了目前有关 CPB 时 XII 因子缺乏症管理的建议。
Cardiopulmonary Bypass in a Pediatric Patient with Factor XII Deficiency
Safe use of cardiopulmonary bypass (CPB) relies upon the ability to administer, monitor, and reverse anticoagulation. Although rare, the factor XII deficient patient creates a challenge for the perfusionist due to resultant complication in monitoring anticoagulation. There have been proposed strategies to aid in monitoring anticoagulation in the factor XII deficient patient, however documentation of successful monitoring during CPB is infrequent. With use of the Hemochron Signature Elite and ACT+ cartridges, CPB in a factor XII deficient 8-month-old was completed with predictable and reliable anticoagulation monitoring. This case report explores the current suggestions as to factor XII deficiency management with CPB.